2019
DOI: 10.1016/j.placenta.2019.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Elevated protease HtrA4 in the maternal circulation of preeclampsia may contribute to endothelial barrier disruption by cleaving key junctional protein VE-cadherin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(19 citation statements)
references
References 11 publications
1
18
0
Order By: Relevance
“…Likewise, HtrA4 protein in the maternal serum is significantly elevated in early-onset preeclampsia [21][22][23] . Our studies further suggest that elevated circulating HtrA4 can adversely affect the integrity and function of maternal vascular endothelium and may play a role in the pathogenesis of preeclampsia [24][25][26][27][28] .…”
supporting
confidence: 54%
See 1 more Smart Citation
“…Likewise, HtrA4 protein in the maternal serum is significantly elevated in early-onset preeclampsia [21][22][23] . Our studies further suggest that elevated circulating HtrA4 can adversely affect the integrity and function of maternal vascular endothelium and may play a role in the pathogenesis of preeclampsia [24][25][26][27][28] .…”
supporting
confidence: 54%
“…Likewise, HtrA4 protein in the maternal serum is significantly elevated in early-onset preeclampsia [21][22][23] . Our studies further suggest that elevated circulating HtrA4 can adversely affect the integrity and function of maternal vascular endothelium and may play a role in the pathogenesis of preeclampsia [24][25][26][27][28] .However, to date, the normal function of HtrA4 in the human placenta is unknown. Since HtrA4 is expressed in cytotrophoblasts and syncytiotrophoblasts 22,23 , this study aimed to investigate the functional role of HtrA4 in trophoblast syncytialization.…”
mentioning
confidence: 54%
“…Regardless, in the human HTRA4 is highly expressed only in the placenta, setting HtrA4 apart from the other HtrAs. Studies to date suggest that HtrA4 exerts an important role in human placental development and pregnancy health, and in the pathogenesis of pregnancy complications [ 24 , 35 , 36 , 37 , 38 , 39 , 40 ], which will be discussed in detail later in this review.…”
Section: Protein Domain Architecture Tissue Distribution and Key Molecular Characteristics Of Human Htrasmentioning
confidence: 99%
“…Indeed, recombinant human HtrA4 can cleave the main surface receptor for vascular endothelial growth factor (VEGF)-A which is also known as kinase insert domain receptor (KDR), causing an inhibition of VEGF-A action and endothelial dysfunction [ 39 ]. In addition, HtrA4 can cleave the main endothelial junctional protein vascular endothelial (VE)-cadherin, disrupting cell—cell connections and inducing intercellular gaps between endothelial cells [ 40 ]. Furthermore, HtrA4 may cleave other cell surface receptors such as TGF-β type III receptor (TGFβRIII), producing soluble receptors that can inhibit TGF-β function [ 87 ].…”
Section: Function Regulation and Potential Substrates Of Human Htras And Their Involvement Of Various Diseasesmentioning
confidence: 99%
“…Also, the PDZ domain positively in uenced the protease activity, which suggests that there is a requirement for allosteric and inter-molecular interaction network for HTRA4 functions [11]. HTRA4 has been found to be overexpressed in pre-eclampsia (PE), to and directly interact with HTRA1 and HTRA3, and to participate in the process of embryo implantation and decidualization [3,6,12,13,14]. In addition, HTRA4 can interact with antiapoptotic XIAP, caspase 9, and executioner caspase 7 to in uence apoptotic cell death by affecting cytoskeleton homeostasis.…”
Section: Introductionmentioning
confidence: 99%